ArticleBMC genomics2025
Unsupervised evaluation of pre-trained DNA language model embeddings.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Benchmarking genomic foundation models for binary classification of gene fusion breakpoints from DNA sequences.BioData mining · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundDNA Language Models (DLMs) have generated a lot of hope and hype for solving complex genetics tasks. These models have demonstrated remarkable performance in tasks like gene finding, enhancer annotation, and histone modification. However, they have struggled with tasks such as learning individual-level personal transcriptome variation, highlighting the need for robust evaluation approaches. Current evaluation approaches assess models based on multiple downstream tasks, which are computationally demanding and fail to evaluate their ability to learn as generalist agents.
resultsWe propose a framework to evaluate DLM embeddings using unsupervised numerical linear algebra-based metrics RankMe, NESum, and StableRank. Embeddings were generated from six state-of-the-art DLMs: Nucleotide Transformer, DNA-BERT2, HyenaDNA, MistralDNA, GENA-LM, and GROVER, across multiple genomic benchmark datasets. Our analysis revealed several key insights. First, low pairwise Pearson correlations and limited variance captured by the top principal components suggest that DLM embeddings are high-dimensional and non-redundant. Second, GENA-LM frequently demonstrated strong performance across all unsupervised evaluation metrics, often outperforming other models. Third, while all models performed well on supervised classification tasks, GENA-LM achieved the highest accuracy and F1 scores across most datasets. Importantly, we observed a positive correlation between unsupervised metrics and supervised performance, supporting the utility of unsupervised metrics as effective proxies for model quality assessment.
conclusionThis study introduces a computationally efficient framework for evaluating DLMs. Our results show that GENA-LM, DNA-BERT2, and Nucleotide Transformer frequently outperform HyenaDNA and Mistral across both unsupervised and supervised evaluations. Moreover, the observed positive correlations between unsupervised metrics and downstream classification performance highlight the potential of these metrics as effective proxies for assessing model quality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.